Secondary hypertension is usually associated with an earlier age of onset, no family history, and a clear cause, such as renal or endocrine disorders, or iatrogenic triggers, such as the use of oral contraceptives (131)
As supply expands and regulatory scrutiny increases, manufacturers and platforms often find stronger incentives to align distribution rather than compete at the margins of the market
metformin 1000 mg BID led to conflicting results on hyperandrogenism
People who have persistent GI side effects at 8mg often make the pragmatic choice to maintain that dose rather than escalate further
As oral GLP-1s expand the category, commercial strategy, payer alignment, and operational scale may matter just as much as clinical profiles